Why the study?
Does minimally invasive direct coronary artery bypass (MIDCAB) improve perioperative outcomes and 1-year survival compared to conventional off-pump coronary artery bypass grafting (OP-CABG) in patients with acute coronary syndrome unsuitable for stent PCI?
RCT (n=126)
Randomly divided into the experimental and control groups
No
Does minimally invasive direct coronary artery bypass (MIDCAB) improve perioperative outcomes and 1-year survival compared to conventional off-pump coronary artery bypass grafting (OP-CABG) in patients with acute coronary syndrome unsuitable for stent PCI?
Answers are grounded in this paper and cite their sources.
In patients with acute coronary syndrome unsuitable for stenting, MIDCAB offers similar myocardial and echocardiographic recovery as conventional off-pump CABG while significantly reducing operative trauma, bleeding, hospital stay, and 1-year mortality and cardiogenic shock.
BACKGROUND Coronary artery bypass grafting (CABG) is a common procedure to circumvent the obstruction of coronary arteries when stents are unsuitable. CABG is a very traumatic surgery that requires redirecting blood flow to an external pump. Thus, this procedure has many risks during and after surgery, and minimizing these risks would greatly benefit the patients. MATERIAL AND METHODS We selected 126 patients with coronary artery syndrome and who were unsuitable for stent percutaneous coronary intervention. The observation group received minimally invasive direct coronary artery bypass (MIDCAB), while the control group was treated with off-pump CABG. RESULTS Blood markers and echocardiography before and after treatment improved equally in both groups. Neither group exhibited obvious adverse reactions, or liver and kidney function damage. However, surgical bleeding and postoperative observation days were significantly reduced in the MIDCAB group. Death and cardiac shock at the end of follow-up were significantly lower in the MIDCAB group. CONCLUSIONS Overall, the clinical benefits of MIDCAB and OP-CABG were similar, but MIDCAB significantly reduced postoperative hospital stay and intraoperative blood transfusion, and improved clinical prognosis.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2017) conducted an RCT in Acute coronary syndrome unsuitable for stent percutaneous coronary intervention (n=126). Minimally invasive direct coronary artery bypass (MIDCAB) vs. Off-pump coronary artery bypass grafting (OP-CABG) was evaluated on Death at the end of follow-up (1 year after treatment) (p=0.003).
Synapse has enriched 10 related papers. Consider them for comparative context: